Quick Answer
AVANOS MEDICAL, INC. reported Stockholders Equity of $778.20 million for fiscal year 2025.
AVANOS MEDICAL, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $778.20M | -6.1% |
| 2024 | $828.50M | -33.0% |
| 2023 | $1.24B | -4.3% |
| 2022 | $1.29B | +1.6% |
| 2021 | $1.27B | +0.7% |
| 2020 | $1.26B | -0.8% |
| 2019 | $1.27B | -1.9% |
| 2018 | $1.30B | +6.7% |
| 2017 | $1.22B | +10.2% |
| 2016 | $1.10B | +4.5% |
| 2015 | $1.06B | -29.2% |
| 2014 | $1.49B | -28.3% |
| 2013 | $2.08B | +1.1% |
| 2012 | $2.06B | +2.9% |
| 2011 | $2.00B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $778.00M | -36.7% | +0.2% |
| June 30, 2025 | $776.30M | -36.5% | -7.5% |
| March 31, 2025 | $839.40M | -31.6% | +1.3% |
| December 31, 2024 | $828.50M | -33.0% | -32.6% |
| September 30, 2024 | $1.23B | +0.6% | +0.6% |
| June 30, 2024 | $1.22B | -1.0% | -0.5% |
| March 31, 2024 | $1.23B | -5.5% | -0.7% |
| December 31, 2023 | $1.24B | -4.3% | +1.2% |
- AVANOS MEDICAL, INC. showed a decrease of -6.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, AVANOS MEDICAL, INC.’s stockholders equity has declined by 61.0% (from $2.00 billion to $778.20 million).
- The most recent figure is from AVANOS MEDICAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: